The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 07, 2015
Filed:
Jan. 07, 2015
Applicant:
Adamas Pharmaceuticals, Inc., Emeryville, CA (US);
Inventors:
Gregory T. Went, Mill Valley, CA (US);
Timothy J. Fultz, Jasper, GA (US);
Assignee:
Adamas Pharmaceuticals, Inc., Emeryville, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/13 (2006.01); A61K 31/197 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01); A61K 9/50 (2006.01); A61K 31/198 (2006.01); A61K 45/06 (2006.01); A61K 9/00 (2006.01); A61K 9/48 (2006.01);
U.S. Cl.
CPC ...
A61K 31/13 (2013.01); A61K 31/197 (2013.01); A61K 9/1617 (2013.01); A61K 9/1652 (2013.01); A61K 9/2009 (2013.01); A61K 9/2054 (2013.01); A61K 9/2846 (2013.01); A61K 9/5047 (2013.01); A61K 9/5078 (2013.01); A61K 31/198 (2013.01); A61K 45/06 (2013.01); A61K 9/0004 (2013.01); A61K 9/4808 (2013.01); A61K 9/16 (2013.01);
Abstract
Disclosed are compositions comprising amantadine, or a pharmaceutically acceptable salt thereof, and one or more excipients, wherein at least one of the excipients modifies release of amantadine. Methods of administering the same are also provided.
Went, Gregory. (2015). Composition and method for treating neurological disease (U.S. Patent No. 9072697). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9072697
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile